Korean Celltrion Makes First Big Global Move with Acquisition of…
Korean biosimilar firm Celltrion's USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant moment…
See our Cookie Privacy Policy Here